NCCN Task Force: Clinical utility of PET in a variety of tumor types

Donald A. Podoloff, Douglas W. Ball, Edgar Ben-Josef, Al B. Benson, Steven J. Cohen, R. Edward Coleman, Dominique Delbeke, Maria Ho, David H. Ilson, Gregory P. Kalemkerian, Richard J. Lee, Jay S. Loeffler, Homer A. Macapinlac, Robert J. Morgan, Barry Alan Siegel, Seema Singhal, Douglas S. Tyler, Richard J. Wong

Research output: Contribution to journalReview article

86 Scopus citations

Abstract

Use of PET is widespread and increasing in the United States, mainly for oncologic applications. In November 2006, the National Comprehensive Cancer Network (NCCN) gathered a panel of experts to review the literature and develop clinical recommendations for using PET scans in lymphoma and non-small cell lung, breast, and colorectal cancers. However, because its use is not restricted to these diseases, and evidence is accumulating for its application in other types of cancers, NCCN convened a second meeting in December 2008 to expand on the initial report. A multidisciplinary panel met to discuss the current data on PET application for various tumor types, including genitourinary, gynecologic, pancreatic, hepatobiliary, thyroid, brain, small cell lung, gastric, and esophageal cancers, and sarcoma and myeloma. This report summarizes the proceedings of this meeting, including discussions of the background of PET, the role of PET in oncology, principles of PET use, emerging applications, and possible future developments.

Original languageEnglish (US)
Pages (from-to)S1-S25
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume7
Issue numberSUPPL. 2
DOIs
StatePublished - 2009
Externally publishedYes

Keywords

  • Biliary tract cancer
  • Brain cancer
  • Esophageal cancer
  • Gastric cancer
  • Genitourinary cancers
  • Gynecological cancers
  • Liver cancer
  • Myeloma
  • PET
  • PET/CT
  • Pancreatic cancer
  • Sarcoma
  • Small cell lung cancer
  • Thyroid cancer

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'NCCN Task Force: Clinical utility of PET in a variety of tumor types'. Together they form a unique fingerprint.

  • Cite this

    Podoloff, D. A., Ball, D. W., Ben-Josef, E., Benson, A. B., Cohen, S. J., Coleman, R. E., Delbeke, D., Ho, M., Ilson, D. H., Kalemkerian, G. P., Lee, R. J., Loeffler, J. S., Macapinlac, H. A., Morgan, R. J., Siegel, B. A., Singhal, S., Tyler, D. S., & Wong, R. J. (2009). NCCN Task Force: Clinical utility of PET in a variety of tumor types. JNCCN Journal of the National Comprehensive Cancer Network, 7(SUPPL. 2), S1-S25. https://doi.org/10.6004/jnccn.2009.0075